Luyi Huang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- Glycosylation and Glycoproteins Research
Papers in
-
- Ubiquitin and proteasome pathways 11
- Glycosylation and Glycoproteins Research 5
- Protein Degradation and Inhibitors 4
- RNA modifications and cancer 4
-
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- Shengyong Yang (17 shared papers)Ni Tang (16 shared papers)Kai Wang (16 shared papers)Zhirong Zhang (4 shared papers)Mengke Qu (1 shared paper)Shanshan He (1 shared paper)Yu Fu (1 shared paper)Xun Sun (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)European Journal of Medicinal Chemistry (3 papers)Cell Death and Disease (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Oncogene (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Luyi Huang
44 papers receiving 1.5k citations
Luyi Huang's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 415
- Molecular Biology 979
- Immunology 166
- Infectious Diseases 141
- Biological Psychiatry 17
Countries citing papers authored by Luyi Huang
This map shows the geographic impact of Luyi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyi Huang more than expected).
Fields of papers citing papers by Luyi Huang
This network shows the impact of papers produced by Luyi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyi Huang. The network helps show where Luyi Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Luyi Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease Hit paper breakdown → | 2018 | 446 |
| 2 | 2020 | 130 | |
| 3 | 2023 | 96 | |
| 4 | 2021 | 85 | |
| 5 | 2023 | 66 | |
| 6 | 2023 | 58 | |
| 7 | 2016 | 54 | |
| 8 | 2004 | 45 | |
| 9 | 2017 | 36 | |
| 10 | 2018 | 36 | |
| 11 | 2017 | 36 | |
| 12 | 2021 | 30 | |
| 13 | 2021 | 28 | |
| 14 | 2020 | 28 | |
| 15 | 2018 | 28 | |
| 16 | 2020 | 25 | |
| 17 | 2016 | 25 | |
| 18 | 2024 | 24 | |
| 19 | 2017 | 24 | |
| 20 | 2023 | 23 |
About Luyi Huang
Luyi Huang is a scholar working on Molecular Biology, Cancer Research, Organic Chemistry, Oncology and Epidemiology, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), Cancer, Hypoxia, and Metabolism (6 papers), Glycosylation and Glycoproteins Research (5 papers), Protein Degradation and Inhibitors (4 papers), RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (3 papers), Diet, Metabolism, and Disease (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Cancer Research (415 citations), Molecular Biology (979 citations), Immunology (166 citations), Infectious Diseases (141 citations) and Biological Psychiatry (17 citations). Luyi Huang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Shengyong Yang, Ni Tang, Kai Wang, Zhirong Zhang, Mengke Qu, Shanshan He, Yu Fu, Xun Sun, Luyao Wang and Qing Lin. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Cell Death and Disease, Journal of Experimental & Clinical Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.